Skip to content

Clinical trials

Phase 1/2 Retinal Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Diseases Phase: Phase 1/2 Country / region: United States Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20092
20101
20111
20181
20195
20201
20211
20233
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated5
Active, not recruiting4
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)3
AsclepiX Therapeutics, Inc.2
ProQR Therapeutics2
David M. Brown, M.D.1
Editas Medicine, Inc.1
Elisigen, Inc.1
Gyroscope Therapeutics Limited1
Laboratoires Thea1
PYC Therapeutics1
SparingVision1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Diseases17
Eye Diseases10
Retinal Degeneration8
Macular Degeneration6
Eye Diseases, Hereditary5
Vision Disorders4
Central Serous Chorioretinopathy3
Eye Abnormalities3
Retinal Dystrophies3
Retinitis Pigmentosa3

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.